{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:55:51Z","timestamp":1793148951907,"version":"4.5.0"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discover Nano"],"DOI":"10.1186\/s11671-025-04244-4","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T08:02:16Z","timestamp":1743580936000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Nanomedicine approaches to enhance the effectiveness of meropenem: a strategy to tackle antimicrobial resistance"],"prefix":"10.1186","volume":"20","author":[{"given":"Yohannes","family":"Mengesha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"key":"4244_CR1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.mib.2019.10.008","volume":"51","author":"MI Hutchings","year":"2019","unstructured":"Hutchings MI, Truman AW, Wilkinson B. Antibiotics: past, present and future. Curr Opin Microbi. 2019;51:72\u201380.","journal-title":"Curr Opin Microbi"},{"issue":"11","key":"4244_CR2","doi-asserted-by":"publisher","first-page":"100331","DOI":"10.1016\/j.envadv.2022.100331","volume":"1","author":"KW Chin","year":"2023","unstructured":"Chin KW, Tiong HL, Luang-In V, Ma NL. An overview of antibiotic and antibiotic resistance. Environ Adv. 2023;1(11):100331.","journal-title":"Environ Adv."},{"key":"4244_CR3","doi-asserted-by":"publisher","first-page":"1305294","DOI":"10.3389\/fphar.2023.13052","volume":"14","author":"EM Halawa","year":"2024","unstructured":"Halawa EM, Fadel M, Al-Rabia MW, Behairy A, Nouh NA, Abdo M, Olga R, Fericean L, Atwa AM, El-Nablaway M, Abdeen A. Antibiotic action and resistance: updated review of mechanisms, spread, influencing factors, and alternative approaches for combating resistance. Front Pharma. 2024;14:1305294. https:\/\/doi.org\/10.3389\/fphar.2023.13052.","journal-title":"Front Pharma"},{"key":"4244_CR4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ejmech.2017.03.022","volume":"131","author":"MI El-Gamal","year":"2017","unstructured":"El-Gamal MI, Brahim I, Hisham N, Aladdin R, Mohammed H, Bahaaeldin A. Recent updates of carbapenem antibiotics. Eur J Med Chem. 2017;131:185\u201395.","journal-title":"Eur J Med Chem"},{"issue":"9","key":"4244_CR5","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.52711\/0974-360X.2021.00878","volume":"14","author":"M Abed","year":"2021","unstructured":"Abed M, Yousuf S. A Review on meropenem. Res J Pharma Technol. 2021;14(9):5034\u20138.","journal-title":"Res J Pharma Technol."},{"key":"4244_CR6","unstructured":"World Health Organization Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics. 2017. Available online: http:\/\/www.who.int\/medicines\/publications\/WHO-PPL-Short_Sum-mary_25Feb-ET_NM_WHO.pdAccessed  1 Nov 2024."},{"key":"4244_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0924-8579(96)00347-0","volume":"8","author":"JL Blumer","year":"1997","unstructured":"Blumer JL. Meropenem: evaluation of a new generation carbapenem. Int J Antimicrob Agents. 1997;8:73\u201392.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"4244_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2165\/00003495-199550010-00007","volume":"50","author":"LR Wiseman","year":"1995","unstructured":"Wiseman LR, Wagstaff AJ, Brogden RN, Bryson HM. Meropenem: a review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs. 1995;50(1):73\u2013101. https:\/\/doi.org\/10.2165\/00003495-199550010-00007.","journal-title":"Drugs"},{"key":"4244_CR9","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0891-5520(03)00065-5","volume":"17","author":"WA Craig","year":"2003","unstructured":"Craig WA. Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid. Infect Dis Clin North Am. 2003;17:479\u2013501.","journal-title":"Infect Dis Clin North Am"},{"key":"4244_CR10","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1086\/344653","volume":"36","author":"GL Drusano","year":"2003","unstructured":"Drusano GL. Prevention of resistance: a goal for dose selection for antimicrobial agents. Clin Infect Dis. 2003;36:S42\u201350.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"4244_CR11","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2165\/00003495-200059030-00016","volume":"59","author":"M Hurst","year":"2000","unstructured":"Hurst M, Lamb HM. Meropenem: a review of its use in patients in intensive care. Drugs. 2000;59(3):653\u201380. https:\/\/doi.org\/10.2165\/00003495-200059030-00016.","journal-title":"Drugs"},{"issue":"1","key":"4244_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1039\/C2EM30692A","volume":"15","author":"DM Aruguete","year":"2013","unstructured":"Aruguete DM, Kim B, Hochella MF, et al. Antimicrobial nanotechnology: its potential for the effective management of microbial drug resistance and implications for research needs in microbial nanotoxicology. Environ Sci Processes Impac. 2013;15(1):93\u2013102.","journal-title":"Environ Sci Processes Impac"},{"key":"4244_CR13","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.3389\/fmicb.2018.01441","volume":"9","author":"PV Baptista","year":"2018","unstructured":"Baptista PV, McCusker MP, Carvalho A, et al. Nano-strategies to fight multidrug resistant bacteria \u2014 a battle of the titans. Front Microbi. 2018;9:1441.","journal-title":"Front Microbi"},{"key":"4244_CR14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4236\/pp.2012.32027","volume":"3","author":"T Saito","year":"2012","unstructured":"Saito T, Sawazaki R, Ujiie K, Oda M, Saitoh H. Possible factors involved in oral inactivity of meropenem, a carbapenem antibiotic. Pharmacol Pharm. 2012;3:201\u20136.","journal-title":"Pharmacol Pharm"},{"issue":"10","key":"4244_CR15","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.3201\/eid1710.110655","volume":"17","author":"P Nordmann","year":"2011","unstructured":"Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011;17(10):1791\u20138.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"4244_CR16","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1128\/CMR.05035-11","volume":"25","author":"LS Tzouvelekis","year":"2012","unstructured":"Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. Carbapenemases in Klebsiella pneumoniae and other enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev. 2012;25(4):682\u2013707.","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"4244_CR17","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.cmi.2019.04.013","volume":"25","author":"E Durante-Mangoni","year":"2019","unstructured":"Durante-Mangoni E, Andini R, Zampino R. Management of carbapenem-resistant Enterobacteriaceae infections. Clin Microbiol Infect. 2019;25(8):943\u201350.","journal-title":"Clin Microbiol Infect"},{"key":"4244_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz830","author":"Y Doi","year":"2019","unstructured":"Doi Y. Treatment options for carbapenem-resistant gram-negative bacterial infections. Clin Infect Dis. 2019. https:\/\/doi.org\/10.1093\/cid\/ciz830.","journal-title":"Clin Infect Dis"},{"key":"4244_CR19","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.3389\/fmicb.2019.02777","volume":"10","author":"X Song","year":"2019","unstructured":"Song X, Wu Y, Cao L, Yao D, Long M. Is Meropenem as a Monotherapy truly incompetent for meropenem-nonsusceptible bacterial strains? A pharmacokinetic\/pharmacodynamic modeling with monte carlo simulation. Front Microbiol. 2019;10:2777. https:\/\/doi.org\/10.3389\/fmicb.2019.02777.","journal-title":"Front Microbiol"},{"issue":"2","key":"4244_CR20","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3201\/eid2402.171268","volume":"24","author":"S Nakano","year":"2018","unstructured":"Nakano S, Fujisawa T, Ito Y, Chang B, Matsumura Y, Yamamoto M, Nagao M, Suga S, Ohnishi M, Ichiyama S. Spread of meropenem-resistant streptococcus pneumoniae serotype 15A-ST63 clone in Japan, 2012\u20132014. Emerg Infect Dis. 2018;24(2):275\u201383. https:\/\/doi.org\/10.3201\/eid2402.171268.","journal-title":"Emerg Infect Dis"},{"key":"4244_CR21","unstructured":"World Health Organization. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics, 2017. Available: https:\/\/www.who.int\/medicines\/publications\/global-priority-list-antibiotic-resistant-bacteria\/en\/ Accessed 19 Nov 2024."},{"key":"4244_CR22","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02000-20","author":"KM Kazmierczak","year":"2021","unstructured":"Kazmierczak KM, Karlowsky JA, de Jonge BLM, Stone GG, Sahm DF. Epidemiology of carbapenem resistance determinants identified in meropenem-nonsusceptible enterobacterales collected as part of a global surveillance program, 2012 to 2017. Antimicrob Agents Chemother. 2021. https:\/\/doi.org\/10.1128\/AAC.02000-20.","journal-title":"Antimicrob Agents Chemother"},{"key":"4244_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.810414","volume":"12","author":"R Varghese","year":"2022","unstructured":"Varghese R, Basu S, Neeravi A, Pragasam A, Aravind V, Gupta R, Miraclin A, Ramaiah S, Anbarasu Aand Veeraraghavan B. Emergence of meropenemresistance among cefotaximenon-susceptible streptococcuspneumoniae: evidenceand challenges. Front Microbiol. 2022;12: 810414. https:\/\/doi.org\/10.3389\/fmicb.2021.810414.","journal-title":"Front Microbiol"},{"key":"4244_CR24","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2147\/IDR.S233808","volume":"13","author":"NA Hassuna","year":"2020","unstructured":"Hassuna NA, Darwish MK, Sayed M, Ibrahem RAly. molecular epidemiology and mechanisms of high-level resistance to meropenem and imipenem in Pseudomonas aeruginosa. Infect Drug Resist. 2020;13:285\u201393. https:\/\/doi.org\/10.2147\/IDR.S233808.","journal-title":"Infect Drug Resist"},{"issue":"2","key":"4244_CR25","doi-asserted-by":"publisher","first-page":"80","DOI":"10.34172\/jsums.2019.14","volume":"21","author":"F Kakian","year":"2019","unstructured":"Kakian F, Zamzad B, Gholipour A, Zamanzad K. Determination of antibiotic resistance and minimum inhibitory concentration of meropenem and imipenem growth in Klebsiella strains isolated from urinary tract infection in Shahrekord educational hospitals. J Shahrekord University Med Sci. 2019;21(2):80\u20135.","journal-title":"J Shahrekord University Med Sci."},{"issue":"1","key":"4244_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13756-024-01389-2","volume":"13","author":"MY Gobezie","year":"2024","unstructured":"Gobezie MY, Hassen M, Tesfaye NA, Solomon T, Demessie MB, Kassa TD, Wendie TF, Andualem A, Alemayehu E, Belayneh YM. Prevalence of meropenem-resistant Pseudomonas aeruginosa in ethiopia: a systematic review and meta-analysis. Antimicrobi Resista Infect Control. 2024;13(1):37.","journal-title":"Antimicrobi Resista Infect Control"},{"issue":"2","key":"4244_CR27","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ijantimicag.2012.04.004","volume":"40","author":"JY Lee","year":"2012","unstructured":"Lee JY, Ko KS. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-beta-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea. Int J Antimicrob Agents. 2012;40(2):168\u201372. https:\/\/doi.org\/10.1016\/j.ijantimicag.2012.04.004.","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"4244_CR28","first-page":"376","volume":"7","author":"Y Xu","year":"2015","unstructured":"Xu Y, Gu B, Huang M, Liu H, Xu T, Xia W, Wang T. Epidemiology of carbapenem resistant Enterobacteriaceae (CRE) during 2000\u20132012 in Asia. J Thorac Dis. 2015;7(3):376.","journal-title":"J Thorac Dis"},{"key":"4244_CR29","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1186\/s12879-023-08610-4","volume":"23","author":"KA Hammour","year":"2023","unstructured":"Hammour KA, Abu-Farha R, Itani R, Karout S, Allan A, Manaseer Q, Hammour WA. The prevalence of carbapenem resistance gram negative pathogens in a tertiaryteaching hospital in jordan. BMC Infect Dis. 2023;23:634.","journal-title":"BMC Infect Dis"},{"issue":"11","key":"4244_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2024.102186","volume":"32","author":"AA Alshehri","year":"2024","unstructured":"Alshehri AA, Irekeola AA. Prevalence of carbapenem-resistant enterobacterales (CRE) in Saudi Arabia: a systematic review and meta-analysis. Saudi Pharm J. 2024;32(11): 102186.","journal-title":"Saudi Pharm J"},{"key":"4244_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e34926","volume":"10","author":"AA Irekeola","year":"2024","unstructured":"Irekeola AA, et al. High prevalence of carbapenem-resistant enterobacterales (CRE) in human samples from nigeria: a systematic review and meta-analysis. Heliyon. 2024;10: e34926.","journal-title":"Heliyon"},{"issue":"4","key":"4244_CR32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.4103\/ljms.ljms_55_21","volume":"5","author":"HM Gargoum","year":"2021","unstructured":"Gargoum HM, Muftah Muftah M, Alsieah Zinab M, Khadija E. prevalence of meropenem and imipenem resistance in gram-negative uropathogens in ibn sina clinic in benghazi-libya. Libyan J Med Sci. 2021;5(4):148\u201352. https:\/\/doi.org\/10.4103\/ljms.ljms_55_21.","journal-title":"Libyan J Med Sci"},{"issue":"4","key":"4244_CR33","doi-asserted-by":"publisher","first-page":"358","DOI":"10.4314\/ajcem.v23i4.4","volume":"23","author":"W Jamal","year":"2022","unstructured":"Jamal W, Iregbu K, Fadhli A, Khodakhast F, Nwajiobi-Princewill P, Medugu N, Rotimi VO. A point-prevalence survey of carbapenem-resistant Enterobacteriaceae in two different cities in Kuwait and Nigeria: une enqu\u00eate sur la pr\u00e9valence ponctuelle des ent\u00e9robact\u00e9ries r\u00e9sistantes aux carbap\u00e9n\u00e8mes dans deux villes diff\u00e9rentes du kowe\u00eft et du nigeria. Afr J Clin Exper Microbiol. 2022;23(4):358\u201368.","journal-title":"Afr J Clin Exper Microbiol."},{"key":"4244_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-024-03530-y","author":"SH Haji","year":"2024","unstructured":"Haji SH, Ganjo AR, Faraj TA, Fatah MH, Smail SB. The enhanced antibacterial and antibiofilm properties of titanium dioxide nanoparticles biosynthesized by multidrug-resistant Pseudomonas aeruginosa. BMC Microbiol. 2024. https:\/\/doi.org\/10.1186\/s12866-024-03530-y.","journal-title":"BMC Microbiol"},{"key":"4244_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2092","author":"SCJ Jorgensen","year":"2018","unstructured":"Jorgensen SCJ, Rybak MJ. Meropenem and vaborbactam: stepping up the battle against carbapenem-resistant Enterobacteriaceae. Pharmacotherapy. 2018. https:\/\/doi.org\/10.1002\/phar.2092.","journal-title":"Pharmacotherapy"},{"key":"4244_CR36","doi-asserted-by":"publisher","DOI":"10.2144\/fsoa-2019-0098","author":"AA Elshamy","year":"2020","unstructured":"Elshamy AA, Aboshanab KM. A review on bacterial resistance to carbapenems: epidemiology, detection and treatment options. Future Sci OA. 2020. https:\/\/doi.org\/10.2144\/fsoa-2019-0098.","journal-title":"Future Sci OA"},{"key":"4244_CR37","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2147\/IDR.S156995","volume":"11","author":"I Ghai","year":"2018","unstructured":"Ghai I, Ghai S. Understanding antibiotic resistance via outer membrane permeability. Infect Drug Resist. 2018;11:523\u201330. https:\/\/doi.org\/10.2147\/IDR.S156995.","journal-title":"Infect Drug Resist"},{"key":"4244_CR38","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/prot.24185","volume":"81","author":"QT Tran","year":"2013","unstructured":"Tran QT, Williams S, Farid R, Erdemli G, Pearlstein R. The translocation kinetics of antibiotics through porin OmpC: insights from structure-based solvation mapping using watermap. Proteins. 2013;81:291\u20139. https:\/\/doi.org\/10.1002\/prot.24185.","journal-title":"Proteins"},{"issue":"3","key":"4244_CR39","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3390\/antibiotics11030421","volume":"11","author":"C Aurilio","year":"2022","unstructured":"Aurilio C, Sansone P, Barbarisi M, Pota V, Giaccari LG, Coppolino F, Barbarisi A, Passavanti MB, Pace MC. Mechanisms of action of carbapenem resistance. Antibiotics. 2022;11(3):421. https:\/\/doi.org\/10.3390\/antibiotics11030421.","journal-title":"Antibiotics"},{"key":"4244_CR40","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1126\/science.1220761","volume":"337","author":"KJ Forsberg","year":"2012","unstructured":"Forsberg KJ, Reyes A, Wang B, Selleck EM, Sommer MO, Dantas G. The shared antibiotic resistome of soil bacteria and human pathogens. Science. 2012;337:1107\u201311. https:\/\/doi.org\/10.1126\/science.1220761.","journal-title":"Science"},{"key":"4244_CR41","doi-asserted-by":"publisher","first-page":"e00088","DOI":"10.1128\/CMR.00088-17","volume":"31","author":"SR Partridge","year":"2018","unstructured":"Partridge SR, Kwong SM, Firth N, Jensen SO. Mobile genetic elements associated with antimicrobial resistance. Clin Microbiol Rev. 2018;31:e00088-e117. https:\/\/doi.org\/10.1128\/CMR.00088-17.","journal-title":"Clin Microbiol Rev"},{"key":"4244_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.610109","volume":"11","author":"L Chen","year":"2021","unstructured":"Chen L, Tan P, Zeng J, Yu X, Cai Y, Liao K, Guo P, Chen Y, Wu Z, Qu P, et al. Impact of an intervention to control Imipenem-resistant acinetobacter baumannii and Its resistance mechanisms: an 8-year survey. Front Microbiol. 2021;11: 610109.","journal-title":"Front Microbiol"},{"key":"4244_CR43","first-page":"4","volume":"31","author":"MM Garcia","year":"2013","unstructured":"Garcia MM. Carbapenemases: a real threat. APUA Newsl. 2013;31:4\u20136.","journal-title":"APUA Newsl"},{"issue":"1","key":"4244_CR44","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1177\/2049936115621709","volume":"3","author":"G Meletis","year":"2016","unstructured":"Meletis G. Carbapenem resistance: overview of the problem and future perspectives. Ther Adv Infect Dis. 2016;3(1):1521. https:\/\/doi.org\/10.1177\/2049936115621709.","journal-title":"Ther Adv Infect Dis"},{"key":"4244_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/1321487","volume":"2016","author":"MC Sonmezer","year":"2016","unstructured":"Sonmezer MC, Ertem G, Erdinc FS, Kilic EK, Tulek N, Adiloglu A, Hatipoglu C. Evaluation of risk factors for antibiotic resistance in patients with nosocomial infections caused by Pseudomonas aeruginosa. Canadi J Infect Dis Med Microbiol. 2016;2016:1\u20139. https:\/\/doi.org\/10.1155\/2016\/1321487.","journal-title":"Canadi J Infect Dis Med Microbiol"},{"key":"4244_CR46","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.2147\/CIA.S406214","volume":"18","author":"F Colkesen","year":"2023","unstructured":"Colkesen F, Tarakc\u0131 A, Eroglu E, Kacar F, Armagan SO, Can S, Erol B, Aksay O, Colkesen F. carbapenem-resistant Klebsiella pneumoniae infection and its risk factors in older adult patients. Clin Interv Aging. 2023;18:1037\u201345.","journal-title":"Clin Interv Aging"},{"key":"4244_CR47","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz027","author":"SE Richter","year":"2019","unstructured":"Richter SE, Miller L, Needleman J, Uslan DZ, Bell D, Watson K, Humphries R, McKinnell JA. Risk factors for development of carbapenem resistance among gram-negative rods. Open Forum Infect Dis. 2019. https:\/\/doi.org\/10.1093\/ofid\/ofz027.","journal-title":"Open Forum Infect Dis"},{"key":"4244_CR48","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1007\/s10096-019-03644-6","volume":"38","author":"F Labaste","year":"2019","unstructured":"Labaste F, Grossac J, Bounes FV, Conil JM, Ruiz S, Seguin T, Grare M, Fourcade O, Minville V, Georges B. Risk factors for acquisition of carbapenem-resistance during treatment with carbapenem in the intensive care unit: a prospective study. Eur J Clin Microbiol Infect Dis. 2019;38:2077\u201385.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"4244_CR49","first-page":"398","volume":"55","author":"S Cetin","year":"2021","unstructured":"Cetin S, Dokmetas I, Hamidi AA, Bayraktar B, Gunduz A, Sevgi DY. Comparison of risk factors and outcomes in carbapenem-resistant and carbapenem-susceptible gram-negative bacteremia. Med Bull Sisli Etfal Hosp. 2021;55(3):398\u2013404.","journal-title":"Med Bull Sisli Etfal Hosp"},{"key":"4244_CR50","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-13-9871-1","volume-title":"Antibacterial drug discovery to combat MDR: natural compounds, nanotechnology and novel synthetic sources","year":"2019","unstructured":"Ahmad I, Ahmad S, Rumbaugh KP, editors. Antibacterial drug discovery to combat MDR: natural compounds, nanotechnology and novel synthetic sources. Singapore: Springer; 2019. https:\/\/doi.org\/10.1007\/978-981-13-9871-1."},{"key":"4244_CR51","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/ja.2017.73","volume":"70","author":"B Kulengowski","year":"2017","unstructured":"Kulengowski B, Campion JJ, Feola DJ, Burgess DS. Effect of the meropenem MIC on the killing activity of meropenem and polymyxin B in combination against KPC-producing klebsiella pneumonia. J Antibiot. 2017;70:974\u20138.","journal-title":"J Antibiot"},{"key":"4244_CR52","doi-asserted-by":"publisher","first-page":"7232","DOI":"10.1128\/AAC.01713-15","volume":"59","author":"E Wenzler","year":"2015","unstructured":"Wenzler E, Gotfried MH, Loutit JS, Durso S, Griffith DC, Dudley MN, et al. Meropenem-RPX7009 concentrations in plasma, epithelial lining fluid, and alveolar macrophages of healthy adult subjects. Antimicrob Agents Chemother. 2015;59:7232\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"4244_CR53","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.eng.2024.02.010","volume":"38","author":"Z Ling","year":"2024","unstructured":"Ling Z, Farley AJM, Lankapalli A, et al. The triple combination of meropenem, avibactam, and a metallo-blactamase inhibitor optimizes antibacterial coverage against different b-lactamase producers. Engineering. 2024;38:124\u201332.","journal-title":"Engineering"},{"issue":"4","key":"4244_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2024.116558","volume":"110","author":"HM Refat","year":"2024","unstructured":"Refat HM, Selim M, Fatma AM, Gomaa MY, Alshahrani NA, Kamel KM, Aboshanab KM, Elsayed,. Colistin, doxycycline and Labetalol-meropenem combination are the most active against XDR-carbapenem-resistant acinetobacter baumannii: role of a novel transferrable plasmid conferring carbapenem resistance. Diagn Microbiol Infect Dis. 2024;110(4): 116558.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"4244_CR55","doi-asserted-by":"publisher","first-page":"1264492","DOI":"10.3389\/fmed.2023.1264492","volume":"10","author":"V Kryzhevskyi","year":"2023","unstructured":"Kryzhevskyi V, Strokous V, Lifshyts Y, Rybianets Y, Oberniak A, Krikunov A, Iungin O, Potochilova V, Rudnieva K, Petakh P, Kamyshnyi A, Moshynets O. Case report: azithromycin-meropenem combination therapy as a low-cost approach to combat PDR gram-negative infections of war wounds in Ukraine. Front Med. 2023;10:1264492. https:\/\/doi.org\/10.3389\/fmed.2023.1264492.","journal-title":"Front Med"},{"key":"4244_CR56","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.2147\/IDR.S172137","volume":"11","author":"Z Jiang","year":"2018","unstructured":"Jiang Z, He X, Li J. Synergy effect of meropenem-based combinations against Acinetobacter baumannii: a systematic review and meta-analysis. Infect Drug Resist. 2018;11:1083\u201395. https:\/\/doi.org\/10.2147\/IDR.S172137.","journal-title":"Infect Drug Resist"},{"issue":"9","key":"4244_CR57","doi-asserted-by":"publisher","first-page":"29756","DOI":"10.1021\/acsomega.4c03352","volume":"2024","author":"SP Selvaraj","year":"2024","unstructured":"Selvaraj SP, Lin K-H, Lin W-C, You M-F, Li T-L, Chen J-Y. rejuvenation of meropenem by conjugation with tilapia piscidin-4 peptide targeting NDM-1 escherichia coli. ACS Omega. 2024;2024(9):29756\u201364.","journal-title":"ACS Omega"},{"key":"4244_CR58","doi-asserted-by":"publisher","DOI":"10.1007\/s00284-022-03061-7","author":"A Parmanik","year":"2022","unstructured":"Parmanik A, Das S, Kar B, Bose A, Dwivedi GR, Pandey MM. Current treatment strategies against multidrug-resistant bacteria: a review. Curr Microbiol. 2022. https:\/\/doi.org\/10.1007\/s00284-022-03061-7.","journal-title":"Curr Microbiol"},{"issue":"188","key":"4244_CR59","doi-asserted-by":"publisher","first-page":"106515","DOI":"10.1016\/j.ejps.2023.106515","volume":"1","author":"F Aflakian","year":"2023","unstructured":"Aflakian F, Mirzavi F, Aiyelabegan HT, Soleimani A, Navashenaq JG, Karimi-Sani I, Zomorodi AR, Vakili-Ghartavol R. nanoparticles-based therapeutics for the management of bacterial infections: a special emphasis on FDA approved products and clinical trials. Euro J Pharm Sci. 2023;1(188):106515.","journal-title":"Euro J Pharm Sci."},{"issue":"13","key":"4244_CR60","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3390\/antibiotics13020121","volume":"2024","author":"P Ioannou","year":"2024","unstructured":"Ioannou P, Baliou S, Samonis G. Nanotechnology in the diagnosis and treatment of antibiotic-resistant infections. Antibiotics. 2024;2024(13):121. https:\/\/doi.org\/10.3390\/antibiotics13020121.","journal-title":"Antibiotics"},{"issue":"2","key":"4244_CR61","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.21608\/bfsa.2022.271825","volume":"45","author":"S Hadiya","year":"2022","unstructured":"Hadiya S, Ibrahem RA, Abd El-Baky RM, Elsabahy M, Aly SA. Nanoparticles based combined antimicrobial drug delivery system as a solution for bacterial resistance. Bull Pharm Sci Assiut University. 2022;45(2):1121\u201341.","journal-title":"Bull Pharm Sci Assiut University."},{"key":"4244_CR62","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1039\/D4PM00032C","volume":"1","author":"SK Mondal","year":"2024","unstructured":"Mondal SK, Chakraborty S, Mannab S, Manda SM. Antimicrobial nanoaprticles current landscape and future challenges. RSC Pharm. 2024;1:388\u2013402.","journal-title":"RSC Pharm."},{"issue":"2","key":"4244_CR63","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1590\/S1516-89132013005000011","volume":"57","author":"S Ranghar","year":"2014","unstructured":"Ranghar S, Sirohi P, Verma P, Agarwa V. Nanoparticle-based drug delivery systems: promising approaches against infections. Braz Arch Biol Technol. 2014;57(2):209\u201322.","journal-title":"Braz Arch Biol Technol"},{"key":"4244_CR64","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fchem.2020.00286","volume":"8","author":"Y-C Yeh","year":"2020","unstructured":"Yeh Y-C, Huang T-H, Yang S-C, Chen C-C, Fang J-Y. Nano-based drug delivery or targeting to eradicate bacteria for infection mitigation: a review of recent advances. Front Chem. 2020;8:286. https:\/\/doi.org\/10.3389\/fchem.2020.00286.","journal-title":"Front Chem"},{"issue":"1","key":"4244_CR65","doi-asserted-by":"publisher","first-page":"56","DOI":"10.5114\/ms.2016.58807","volume":"32","author":"G Michalak","year":"2016","unstructured":"Michalak G, G\u0142uszek K, Piktel E, Deptu\u0142a P, Puszkarz I, Niemirowicz K, Bucki R. Polymeric nanoparticles\u2013a novel solution for delivery of antimicrobial agents. Med Stud\/Studia Medycz. 2016;32(1):56\u201362.","journal-title":"Med Stud\/Studia Medycz."},{"issue":"5","key":"4244_CR66","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.jscs.2011.11.004","volume":"18","author":"JP Raval","year":"2014","unstructured":"Raval JP, Naik DR, Amin KA, Patel PS. Controlled-release and antibacterial studies of Doxycycline-loaded poly (\u025b-caprolactone) microspheres. J Saudi Chem Soc. 2014;18(5):566\u201373.","journal-title":"J Saudi Chem Soc"},{"key":"4244_CR67","first-page":"1343","volume":"8","author":"R Khanum","year":"2016","unstructured":"Khanum R, Qureshi MJ, Mohandas K. Antibiofilm Potential of Meropenem-Loaded Poly (\u03b5-Caprolactone) Nano particles Against Klebsiella pneumoniae. Int J Pharm Clin Res. 2016;8:1343\u201350.","journal-title":"Int J Pharm Clin Res."},{"issue":"3","key":"4244_CR68","doi-asserted-by":"publisher","first-page":"e1440","DOI":"10.1002\/vms3.1440","volume":"10","author":"S Hajimohammadi","year":"2024","unstructured":"Hajimohammadi S, Momtaz H, Tajbakhsh E. Fabrication and antimicrobial properties of novel meropenem-honey encapsulated chitosan nanoparticles against multiresistant and biofilm-forming Staphylococcus aureus as a new antimicrobial agent. Vet Med Sci. 2024;10(3):e1440.","journal-title":"Vet Med Sci"},{"issue":"174","key":"4244_CR69","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.carbpol.2017.07.030","volume":"15","author":"A Abdelkader","year":"2017","unstructured":"Abdelkader A, El-Mokhtar MA, Abdelkader O, Hamad MA, Elsabahy M, El-Gazayerly ON. Ultrahigh antibacterial efficacy of meropenem-loaded chitosan nanoparticles in a septic animal model. Carbohyd Polym. 2017;15(174):1041\u201350.","journal-title":"Carbohyd Polym"},{"issue":"22","key":"4244_CR70","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.2217\/nnm-2022-0314","volume":"18","author":"S Hadiya","year":"2023","unstructured":"Hadiya S, Ibrahem RA, Abd RM, El-Baky ME, Hussein AMR, Tolba MEM, Aly SA. Nano-ciprofloxacin\/meropenem exhibit bactericidal activity against gram-negative bacteria and rescue septic rat model. Nanomedicine. 2023;18(22):1553\u201366. https:\/\/doi.org\/10.2217\/nnm-2022-0314.","journal-title":"Nanomedicine"},{"issue":"1","key":"4244_CR71","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1186\/s12879-024-09522-7","volume":"24","author":"MS Amini","year":"2024","unstructured":"Amini MS, Baseri Salehi M, Bahador N. Evaluating the antibacterial effect of meropenem-loaded chitosan\/sodium tripolyphosphate (TPP) nanoparticles on acinetobacter baumannii isolated from hospitalized patients. BMC Infect Dis. 2024;24(1):631.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"4244_CR72","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.nano.2014.09.014","volume":"11","author":"Y Wang","year":"2015","unstructured":"Wang Y, Zhao Q, Han N, et al. Mesoporous silica nanoparticles in drug delivery and biomedical applications. Nanomedicine. 2015;11(2):313\u201327.","journal-title":"Nanomedicine"},{"issue":"3","key":"4244_CR73","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4103\/2230-973X.160844","volume":"5","author":"C Bharti","year":"2015","unstructured":"Bharti C, Nagaich U, Pal AK, et al. Mesoporous silica nanoparticles in target drug delivery system: a review. Int J Pharm Investig. 2015;5(3):124\u201333.","journal-title":"Int J Pharm Investig"},{"issue":"21","key":"4244_CR74","doi-asserted-by":"publisher","first-page":"8788","DOI":"10.1021\/acs.chemmater.3c02192","volume":"35","author":"M Colilla","year":"2023","unstructured":"Colilla M, Vallet-Reg\u00ed M. Organically modified mesoporous silica nanoparticles against bacterial resistance. Chem Mater. 2023;35(21):8788\u2013805.","journal-title":"Chem Mater"},{"key":"4244_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.122529","volume":"631","author":"J Zhuang","year":"2023","unstructured":"Zhuang J, Yiming Yu, Rui Lu. Mesoporous silica nanoparticles as carrier to overcome bacterial drug resistant barriers. Int J Pharm. 2023;631, 122529.","journal-title":"Int J Pharm"},{"issue":"1","key":"4244_CR76","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1080\/21691401.2020.1850466","volume":"48","author":"MY Memar","year":"2020","unstructured":"Memar MY, Yekani M, Ghanbari H, Shahi S, Sharifi S, Maleki DS. Biocompatibility, cytotoxicity and antibacterial effects of meropenem-loaded mesoporous silica nanoparticles against carbapenem-resistant Enterobacteriaceae. Arti Cells, Nanomed, Biotechnol. 2020;48(1) :1354\u201361.","journal-title":"Arti Cells, Nanomed, Biotechnol."},{"issue":"11","key":"4244_CR77","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.3390\/biomedicines11113075","volume":"2023","author":"M Yekani","year":"2023","unstructured":"Yekani M, Azargun R, Sharifi S, Sadri Nahand J, Hasani A, Ghanbari H, Sadat Seyyedi Z, Memar MY, Maleki Dizaj S. Preparation, physicochemical characterization, antimicrobial effects, biocompatibility and cytotoxicity of co-loaded meropenem and vancomycin in mesoporous silica nanoparticles. Biomedicines. 2023;2023(11):3075. https:\/\/doi.org\/10.3390\/biomedicines11113075.","journal-title":"Biomedicines"},{"key":"4244_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102757","volume":"65","author":"A Najafi","year":"2021","unstructured":"Najafi A, Khosravian P, Validi M, Daryasari MP, Drees F, Gholipour A. Antimicrobial action of mesoporous silica nanoparticles loaded with cefepime and meropenem separately against multidrug-resistant (MDR) Acinetobacter baumannii. J Drug Deliv Sci Technol. 2021;65 102757.","journal-title":"J Drug Deliv Sci Technol"},{"key":"4244_CR79","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.3390\/ijms24032104","volume":"24","author":"K Sk\u0142odowski","year":"2023","unstructured":"Sk\u0142odowski K, Chmielewska-Deptu\u0142a SJ, Piktel E, Wolak P, Wollny T, Bucki R. metallic nanosystems in the development of antimicrobial strategies with high antimicrobial activity and high biocompatibility. Int J Mol Sci. 2023;24:2104. https:\/\/doi.org\/10.3390\/ijms24032104.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4244_CR80","doi-asserted-by":"publisher","first-page":"24312","DOI":"10.1038\/srep24312","volume":"2016","author":"ASH Hameed","year":"2016","unstructured":"Hameed ASH, Karthikeyan C, Ahamed AP, Thajuddin N, Alharbi NS, Alharbi SA, Ravi G. In vitro antibacterial activity of ZnO and Nd doped ZnO nanoparticles against ESBL producing escherichia coli and Klebsiella pneumoniae. Sci Rep. 2016;2016(6):24312.","journal-title":"Sci Rep"},{"issue":"7","key":"4244_CR81","doi-asserted-by":"publisher","first-page":"5901","DOI":"10.2147\/IJN.S37397","volume":"2012","author":"S Gurunathan","year":"2012","unstructured":"Gurunathan S, Han JW, Dayem AA, Eppakayala V, Kim JH. Oxidative stress-mediated antibacterial activity of grapheme oxide and reduced graphene oxide in Pseudomonas aeruginosa. Int J Nanomed. 2012;2012(7):5901.","journal-title":"Int J Nanomed"},{"issue":"1","key":"4244_CR82","doi-asserted-by":"publisher","first-page":"167","DOI":"10.22207\/JPAM.17.1.06","volume":"17","author":"BN Singh","year":"2023","unstructured":"Singh BN, Patil PS, Shah H, Ashfaq M, Singh A, Upadhyay GC. Meropenem incorporated ZnO nanoflakes as nano antibiotics: efficient antimicrobial activity against metallo \u03b2-lactamase producing clinical isolates. J Pure Appl Microbiol. 2023;17(1):167\u201379. https:\/\/doi.org\/10.22207\/JPAM.17.1.06.","journal-title":"J Pure Appl Microbiol"},{"issue":"11","key":"4244_CR83","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.3390\/antibiotics11101374","volume":"2022","author":"M El-Telbany","year":"2022","unstructured":"El-Telbany M, Mohamed AA, Yahya G, Abdelghafar A, Abdel-Halim MS, Saber S, Alfaleh MA, Mohamed AH, Abdelrahman F, Fathey HA, et al. Combination of meropenem and zinc oxide nanoparticles; antimicrobial synergism, exaggerated antibiofilm activity, and efficient therapeutic strategy against bacterial keratitis. Antibiotics. 2022;2022(11):1374. https:\/\/doi.org\/10.3390\/antibiotics11101374.","journal-title":"Antibiotics"},{"key":"4244_CR84","doi-asserted-by":"publisher","first-page":"34","DOI":"10.32607\/20758251-2011-3-2-34-55","volume":"3","author":"L Dykman","year":"2011","unstructured":"Dykman L, Khlebtsov N. Gold nanoparticles in biology and medicine: recent advances and prospects. Acta Nat. 2011;3:34\u201355.","journal-title":"Acta Nat"},{"key":"4244_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/ma17071604","author":"D Santosaningsih","year":"2024","unstructured":"Santosaningsih D, Mulyastuti Y, Poejiani S, Putri RF, Dewi L, Arifani H, Nimah YL, Baktir A. The biofilm inhibition properties of glucosamine gold nanoparticles in combination with meropenem against Pseudomonas aeruginosa on the endotracheal tube: a model of biofilm-related ventilatorassociated pneumonia. Materials. 2024. https:\/\/doi.org\/10.3390\/ma17071604.","journal-title":"Materials"},{"issue":"6","key":"4244_CR86","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.12669\/pjms.40.6.7900","volume":"40","author":"S Maqsood","year":"2024","unstructured":"Maqsood S, Taj Y, Satti L, Bakhat S. Synergistic effects of silver nanoparticles in combination with ineffective antibiotics against multidrug resistant salmonella typhi. Pak J Med Sci. 2024;40(6):1168.","journal-title":"Pak J Med Sci"},{"issue":"2","key":"4244_CR87","doi-asserted-by":"publisher","first-page":"22","DOI":"10.36283\/PJMD13-2\/005","volume":"13","author":"S Haque","year":"2024","unstructured":"Haque S, Khatoon A, Ismail K, Memon Z, Afridi FI, Aslam Z, Shah R. Carvacrol silver nanoparticles-an effective antibacterial against carbapenem-resistant acinetobacter isolates unaided and with meropenem. Pakistan J Med Dent. 2024;13(2):22\u201330.","journal-title":"Pakistan J Med Dent."},{"issue":"1","key":"4244_CR88","first-page":"22","volume":"1","author":"FBD Abdel-Wahab","year":"2021","unstructured":"Abdel-Wahab FBD, El Menofy NG, El-Batal AI, Mosallam FM, Abdulal AK. Enhanced antimicrobial activity of the combination of silver nanoparticles and different \u03b2 lactam antibiotics against methicillin resistant Staphylococcus aureus isolates. Azhar Int J Pharm Med. 2021;1(1):22\u201331.","journal-title":"Azhar Int J Pharm Med"},{"issue":"1","key":"4244_CR89","doi-asserted-by":"publisher","first-page":"20685","DOI":"10.1038\/s41598-022-24531-9","volume":"12","author":"M Muddassir","year":"2022","unstructured":"Muddassir M, Raza A, Munir S, Basirat A, Ahmed M, Butt MS, Dar OA, Ahmed SS, Shamim S, Naqvi SZ. Antibacterial efficacy of silver nanoparticles (AgNPs) against metallo-\u03b2-lactamase and extended spectrum \u03b2-lactamase producing clinically procured isolates of Pseudomonas aeruginosa. Sci Rep. 2022;12(1):20685.","journal-title":"Sci Rep"},{"key":"4244_CR90","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/5298565","author":"J Hemmati","year":"2023","unstructured":"Hemmati J, Chegini Z, Arabestani MR. niosomal-based drug delivery platforms: a promising therapeutic approach to fight Staphylococcus aureus drug resistance. J Nanomate. 2023. https:\/\/doi.org\/10.1155\/2023\/5298565.","journal-title":"J Nanomate"},{"key":"4244_CR91","doi-asserted-by":"publisher","first-page":"e35651","DOI":"10.1016\/j.heliyon.2024.e35651","volume":"10","author":"K Paseban","year":"2024","unstructured":"Paseban K, et al. Preparation and optimization of niosome encapsulated meropenem for significant antibacterial and anti-biofilm activity against methicillin-resistant Staphylococcus aureus isolates. Heliyon. 2024;10:e35651.","journal-title":"Heliyon"},{"key":"4244_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.plipres.2017.07.001","volume":"68","author":"MC Teixeira","year":"2017","unstructured":"Teixeira MC, Carbone C, Souto EB. Beyond liposomes: recent advances on lipid based nanostructures for poorly soluble\/poorly permeable drug delivery. Prog Lipid Res. 2017;68:1\u201311.","journal-title":"Prog Lipid Res"},{"key":"4244_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121782","volume":"621","author":"MAB Henostroza","year":"2022","unstructured":"Henostroza MAB, Tavares GD, Yukuyama MN, et al. Antibiotic-loaded lipid-based nanocarrier: a promising strategy to overcome bacterial infection. Int J Pharm. 2022;621 121782.","journal-title":"Int J Pharm"},{"key":"4244_CR94","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.3390\/nano11051251","volume":"11","author":"L Arana","year":"2021","unstructured":"Arana L, Gallego L, Alkorta I. Incorporation of antibiotics into solid lipid nanoparticles: a promising approach to reduce antibiotic resistance emergence. Nanomaterials. 2021;11:1251. https:\/\/doi.org\/10.3390\/nano11051251.","journal-title":"Nanomaterials"},{"key":"4244_CR95","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1208\/s12249-016-0675-z","volume":"18","author":"EKG Mhango","year":"2017","unstructured":"Mhango EKG, Kalhapure RS, Jadhav M, et al. Preparation and optimization of meropenem-loaded solid lipid nanoparticles. in vitro evaluation and molecular modeling. AAPS Pharm Sci Tech. 2017;18:2011\u201325. https:\/\/doi.org\/10.1208\/s12249-016-0675-z.","journal-title":"AAPS Pharm Sci Tech"},{"key":"4244_CR96","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1208\/s12249-022-02381-y","volume":"23","author":"K Rajpoot","year":"2022","unstructured":"Rajpoot K, Prajapati SK, Malaiya A, et al. meropenem-loaded nanostructured lipid carriers for skin and soft tissue infection caused by Staphylococcus aureus: formulation, design, and evaluation. AAPS Pharm Sci Tech. 2022;23:241. https:\/\/doi.org\/10.1208\/s12249-022-02381-y.","journal-title":"AAPS Pharm Sci Tech"},{"key":"4244_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1248\/bpb.b16-00624","volume":"40","author":"AS Abu Lila","year":"2017","unstructured":"Abu Lila AS, Ishida T. Liposomal delivery systems: design optimization and current applications. Biol Pharm Bull. 2017;40:1\u201310.","journal-title":"Biol Pharm Bull"},{"key":"4244_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26072047","author":"M Ferreira","year":"2021","unstructured":"Ferreira M, Ogren M, Dias JNR, Silva M, Gil S, Tavares L, Aires-da-Silva F, Gaspar MM, Aguiar SI. Liposomes as antibiotic delivery systems: a promising nanotechnological strategy against antimicrobial resistance. Molecules. 2021. https:\/\/doi.org\/10.3390\/molecules26072047.","journal-title":"Molecules"},{"issue":"39","key":"4244_CR99","doi-asserted-by":"publisher","first-page":"35442","DOI":"10.1021\/acsomega.3c04893","volume":"8","author":"R Ghosh","year":"2023","unstructured":"Ghosh R, De M. Liposome-based antibacterial delivery: an emergent approach to combat bacterial infections. ACS Omega. 2023;8(39):35442\u201351.","journal-title":"ACS Omega"},{"issue":"5","key":"4244_CR100","first-page":"1","volume":"45","author":"MJ Zahra","year":"2016","unstructured":"Zahra MJ, Hamed H, Mohammad RY, Nosratollah Z, Akbarzadeh A, Morteza M. Evaluation and study of antimicrobial activity of nanoliposomal meropenem against Pseudomonas aeruginosa isolates artificial cells. Nano Biotechnol. 2016;45(5):1\u20136.","journal-title":"Nano Biotechnol"},{"issue":"18","key":"4244_CR101","doi-asserted-by":"publisher","first-page":"5197","DOI":"10.1039\/c3an01085f","volume":"138","author":"SM Mandal","year":"2013","unstructured":"Mandal SM, Saha S, Sengupta J, Pratihar S. Kaajal fights against eye pathogens and is safe for eye make-up: a reinvestigation of an ancient practice. Analyst. 2013;138(18):5197\u20139.","journal-title":"Analyst"},{"issue":"12","key":"4244_CR102","first-page":"100155","volume":"1","author":"MY Memar","year":"2023","unstructured":"Memar MY, Saadat YR, Dizaj SM, Yekani M, Hejazian SM, Niknafs B, Vahed SZ, Sharifi S. Cytotoxicity and biocompatibility of meropenem-loaded graphene oxide and its antibacterial effects against carbapenem-resistant Gram-negative bacteria. Open Nano. 2023;1(12):100155.","journal-title":"Open Nano"},{"key":"4244_CR103","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-981-10-3283-7_5","volume-title":"Frontiers in Nano-therapeutics","author":"N Tasnim","year":"2017","unstructured":"Tasnim N, Nair BG, Krishna KS, Kalagara S, Narayan M, Noveron JC, Joddar B. Nanocomposites. In: Tasnim N, Nair BG, Krishna KS, Kalagara S, Narayan M, Noveron JC, Joddar B, editors. Frontiers in Nano-therapeutics. Springer Singapore; 2017. p. 55\u201366. https:\/\/doi.org\/10.1007\/978-981-10-3283-7_5."},{"key":"4244_CR104","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1186\/s12951-022-01733-x","volume":"20","author":"FA-Z Sayed","year":"2022","unstructured":"Sayed FA-Z, Eissa NG, Shen Y, Hunstad DA, Wooley KL, Elsabahy M. Morphologic design of nanostructures for enhanced antimicrobial activity. J Nano Biotechnol. 2022;20:536. https:\/\/doi.org\/10.1186\/s12951-022-01733-x.","journal-title":"J Nano Biotechnol"},{"issue":"666","key":"4244_CR105","doi-asserted-by":"publisher","first-page":"124846","DOI":"10.1016\/j.ijpharm.2024.124846","volume":"5","author":"M Ranjbar","year":"2024","unstructured":"Ranjbar M, Litkohi HR, Solaimani M. Epirubicin\/folic acid and meropenem loaded on graphene oxide-gelatin can be used as a novel candidate for anti-cancer and antibacterial drug development. Int J Pharm. 2024;5(666):124846.","journal-title":"Int J Pharm"},{"key":"4244_CR106","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/978-981-97-2023-1_12","volume-title":"Nanotechnology based Strategies for combating Antimicrobial Resistance","author":"PP Sarma","year":"2024","unstructured":"Sarma PP, Baruah PK. Nanoemulsions as Drug Carriers to Combat AMR. In: Wani MY, Wani IA, Rai A, editors. Nanotechnology based Strategies for combating antimicrobial resistance. Singapore: Springer Nature Singapore; 2024. p. 313\u201333. https:\/\/doi.org\/10.1007\/978-981-97-2023-1_12."},{"issue":"2024","key":"4244_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.jscs.2024.101896","volume":"28","author":"JP Shabaaz Begum","year":"2024","unstructured":"Shabaaz Begum JP, Sahu P, Vinode R, et al. Antimicrobial Nanoemulsion: a futuristic approach in antibacterial drug delivery system. J Saudi Chem Soc. 2024;28(2024): 101896.","journal-title":"J Saudi Chem Soc"},{"issue":"40","key":"4244_CR108","doi-asserted-by":"publisher","first-page":"26455","DOI":"10.1039\/D2RA03925G","volume":"12","author":"HH Tayeb","year":"2022","unstructured":"Tayeb HH, Moqaddam SA, Hasaballaha NH, Felimbanbd RI. Development of nanoemulsions for the delivery of hydrophobic and hydrophilic compounds against carbapenem-resistant Klebsiella pneumonia. RSC Adv. 2022;12(40):26455\u201362.","journal-title":"RSC Adv"}],"container-title":["Discover Nano"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-025-04244-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11671-025-04244-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-025-04244-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T04:08:56Z","timestamp":1743739736000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11671-025-04244-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4244"],"URL":"https:\/\/doi.org\/10.1186\/s11671-025-04244-4","relation":{},"ISSN":["2731-9229"],"issn-type":[{"value":"2731-9229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"9 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The use of information for academic purposes is authorized.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There is no conflict of interest. The author read and agreed on the manuscript","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}